| |
| |
|
| Insider
Information: |
Davis Stephen |
| Relationship: |
Director |
| City: |
Branford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
344,117 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,518,205 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
344,117 |
|
|
| Total
Value |
$2,518,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -93.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Heron Therapeutics Inc |
HRTX |
Director |
2022-12-16 |
52,032 |
2010-02-17 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
EVP & COO |
2012-06-19 |
0 |
2010-04-06 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-05-02 |
155,231 |
2019-10-09 |
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
136,854 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-10-06 |
4 |
AS |
$15.43 |
$10,803 |
D/D |
(700) |
17,378 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,937 |
17,746 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-10-06 |
4 |
D |
$15.73 |
$3,004 |
D/D |
(191) |
18,078 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-09-06 |
4 |
D |
$15.46 |
$2,953 |
D/D |
(191) |
18,269 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-08-06 |
4 |
D |
$18.22 |
$3,480 |
D/D |
(191) |
18,460 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,625 |
18,579 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-07-06 |
4 |
AS |
$25.65 |
$17,957 |
D/D |
(700) |
18,651 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,715 |
18,715 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-07-06 |
4 |
D |
$25.33 |
$4,838 |
D/D |
(191) |
19,351 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-06-06 |
4 |
D |
$23.94 |
$4,596 |
D/D |
(192) |
19,542 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-05-06 |
4 |
D |
$27.45 |
$5,216 |
D/D |
(190) |
19,623 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-05-16 |
4 |
AS |
$25.29 |
$8,548 |
D/D |
(335) |
19,734 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-04-08 |
4 |
AS |
$28.20 |
$84,594 |
D/D |
(3,000) |
19,813 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2014-09-26 |
4 |
D |
$8.44 |
$866,231 |
D/D |
(102,634) |
20,076 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-04-06 |
4 |
D |
$28.70 |
$66,125 |
D/D |
(2,304) |
22,813 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2021-01-06 |
4 |
S |
$53.34 |
$185,837 |
D/D |
(3,484) |
24,482 |
0 |
% |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2010-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2010-11-22 |
4 |
AS |
$21.92 |
$7,693 |
D/D |
(351) |
25,117 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2021-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,527 |
27,966 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2021-02-04 |
4 |
S |
$50.61 |
$718,409 |
D/D |
(14,195) |
28,900 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-10-09 |
4 |
OE |
$19.65 |
$585,413 |
D/D |
29,792 |
29,792 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2010-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
31,088 |
31,088 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-12 |
4 |
AS |
$25.05 |
$1,380,449 |
D/D |
(55,104) |
36,695 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2023-07-14 |
4 |
AS |
$30.04 |
$3,004,350 |
D/D |
(100,000) |
36,695 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2021-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
43,059 |
0 |
- |
|
95 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
